Strong H1 for Tissue Science Laboratories with more growth prospects along the way
This article was originally published in Clinica
Propelled by particularly strong growth in its core markets, Tissue Science Laboratories (TSL) recorded an impressive 82% jump in sales for the first half of 2004, compared with the same period last year. The company posted revenues of £4.0m ($7.2m) for the first six months of this year, and significantly cut its net loss by 71% to £0.5m.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.